A digital twin technology to revolutionize stent-graft selection for precise, patient-specific surgeries
Achieve perfect procedural outcomes every time with confidence
TEVAR-Twin Solution
TEVAR-Twin offers AI/ML-enabled precision medicine, user-friendly software needing only pre-surgical patient CT images. It relies on clinically-validated high-fidelity numerical models to guide surgeons in selecting the “best-fit” stent-graft.
PATIENTS
51
digital twins with research collaboration with Politecnico di Milano
Clinical centres
34
in 11 countries across Europe and North America
Patents
2
and >10 scientific publications on peer-reviewed journals
About AllStent
The AllStent is a MedTech company founded by a team with >50-years experience in numerical modelling through global collaborations with leading vascular surgeons and stent-graft manufacturers. Additionally, we have deep expertise in MedTech start-up financing and commercialization, and are pursuing US and EU regulatory clearances.
Testimonials
Santi Trimarchi, Policlinico di Milano Hospital (Italy)
The presence kinking prediction and post-operative validation made the results of the simulation very credible.
Javiér Rio Gomez, Hospital General Universitario Gergorio Maranon (Spain)
Before simulations, I didn’t expect big changes in stent configuration changing landing zone. It's interesting to realize how landing zone affects on stent expansion
Theodoros Kratimenos, Evangelismos General Hospital of Athens (Greece)
Preoperative simulation can be a game changer as predicts possible device misalignment
and the best strategy for the patient-specific case!
our partners
Latest News
January 9th, 2025 |
Simulate to innovate: how computational biomechanics is transforming cardiovascular surgery
Giulia Luraghi, AllStent co-founder and Assistant Professor at Politecnico di Milano,
in this interview highlights
how computational biomechanics
is transforming medicine.
November 10th, 2024 |
“H2i” welcomes AllStent to its Medical Innovations early-stage Mentorship Program, University of Toronto
AllStent, with Business, Finance and Regulatory operations in Toronto, Canada; and Research & Development in Milan, Italy, is pleased pleased to announce the on-boarding of AllStent to H2i’s mentoring program.
October 28th, 2024 |
AllStent Accepted into the ECHO 2025 Experiential Training Program to compete for C$250,000 prize
ECHO Entrepreneurship, Canada, is training the next generation of innovators in all aspects of advancing cardiovascular care. ECHO training program aims to bridge the translational gap for cardiovascular innovations.